Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer

Marco Massani; Tommaso Stecca

doi:10.3389/fonc.2023.1138587

Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer

Front Oncol. 2023 Jan 25:13:1138587. doi: 10.3389/fonc.2023.1138587. eCollection 2023.

Authors

Marco Massani¹, Tommaso Stecca¹

Affiliation

¹ First General Surgery Unit, HPB Referral Center, ULSS2 Marca Trevigiana, Treviso, Italy.

No abstract available

Keywords: Neoadjuvant chemo(radio)therapy; borderline resectable pancreatic cancer (BRPC); locally advanced pancreatic cancer (LAPC); lymphnode metastasis; pancreatic cancer.

Publication types

Editorial